2026 Q2 Portfolio Activity
In 2026 Q2, NEXTBio Capital Management LP maintained a portfolio of 27 distinct positions. The most significant new addition was PHARVARIS N V, now representing 1.72% of the total fund value. They heavily accumulated shares in STRUCTURE THERAPEUTICS INC, increasing the position by 134.5%. Conversely, NEXTBio Capital Management LP completely exited their position in TERNS PHARMACEUTICALS INC.
Position History
hover any row below to update
Loading…
Total Positions
27
Quarter
2026 Q2
Top Holding
PTGX (12.4%)
Top 10 Concentration
77.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-27 of 27
NEXTBio Capital Management LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PTGX
PROTAGONIST THE...
|
Healthcare | 12.37% | 11.24% |
#1
1
Prev: #2
|
6.5 |
—
|
-10,286 | -4.5% |
P
S
|
219,333 | $26,885,839 |
$87.34
+77.6%
|
2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
STTK
SHATTUCK LABS I...
|
Healthcare | 11.90% | 9.40% |
#2
1
Prev: #3
|
7.5 |
—
|
577,441 | 18.3% |
P
S
|
3,727,348 | $25,867,795 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 11.56% | 5.19% |
#3
2
Prev: #5
|
5.5 |
—
|
-245,648 | -12.2% |
P
S
|
1,775,759 | $25,126,990 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 7.71% | 2.98% |
#4
10
Prev: #14
|
6.6 |
—
|
179,257 | 134.5% |
P
S
|
312,496 | $16,771,660 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 7.53% | 8.28% |
#5
1
Prev: #4
|
4.0 |
—
|
-110,803 | -11.1% |
P
S
|
889,164 | $16,369,509 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 6.73% | 5.09% |
#6
Prev: #6
|
3.2 |
—
|
5,680 | 4.5% |
P
S
|
131,758 | $14,629,091 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 6.32% | 4.79% |
#7
1
Prev: #8
|
4.5 |
—
|
7,223 | 8.7% |
P
S
|
89,909 | $13,739,893 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 5.09% | 4.95% |
#8
1
Prev: #7
|
3.0 |
—
|
no change | no change |
P
S
|
183,225 | $11,059,461 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 4.98% | 3.87% |
#9
Prev: #9
|
3.0 |
—
|
no change | no change |
P
S
|
426,736 | $10,830,560 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 3.52% | 3.08% |
#10
3
Prev: #13
|
3.9 |
—
|
182,505 | 34.9% |
P
S
|
706,124 | $7,647,323 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 3.11% | 3.44% |
#11
1
Prev: #10
|
3.7 |
—
|
454,500 | 34.1% |
P
S
|
1,787,984 | $6,758,580 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 3.09% | 3.18% |
#12
Prev: #12
|
2.2 |
—
|
no change | no change |
P
S
|
372,856 | $6,711,408 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.87% | 2.57% |
#13
2
Prev: #15
|
3.1 |
—
|
12,000 | 12.6% |
P
S
|
107,223 | $6,232,873 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.33% | 2.34% |
#14
2
Prev: #16
|
1.4 |
—
|
-113 | -0.1% |
P
S
|
131,075 | $5,072,603 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 2.30% | 3.22% |
#15
4
Prev: #11
|
1.9 |
—
|
no change | no change |
P
S
|
1,306,800 | $4,991,976 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 1.77% | 1.56% |
#16
5
Prev: #21
|
1.7 |
—
|
no change | no change |
P
S
|
52,655 | $3,851,187 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.72% | — |
#17
Prev: #—
|
4.2 |
—
|
108,055 | — |
NEW
|
108,055 | $3,736,542 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZLAB
ZAI LAB LTD
|
Healthcare | 1.60% | 1.60% |
#18
2
Prev: #20
|
1.6 |
—
|
no change | no change |
P
S
|
183,362 | $3,483,878 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIOA
BIOAGE LABS INC
|
Healthcare | 1.14% | — |
#19
Prev: #—
|
4.0 |
—
|
100,732 | — |
NEW
|
100,732 | $2,468,941 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 1.02% | — |
#20
Prev: #—
|
3.9 |
—
|
68,249 | — |
NEW
|
68,249 | $2,215,021 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 0.73% | 1.96% |
#21
3
Prev: #18
|
0.3 |
—
|
-65,000 | -35.3% |
P
S
|
119,063 | $1,582,347 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACET
ADICET BIO INC
|
Healthcare | 0.63% | 0.50% |
#22
2
Prev: #24
|
1.3 |
—
|
no change | no change |
P
S
|
157,827 | $1,363,625 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SMMT
SUMMIT THERAPEU...
|
Healthcare | 0.00% | 0.79% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-89,717 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 0.00% | 1.23% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-131,796 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OCS
OCULIS HOLDING ...
|
Healthcare | 0.00% | 1.85% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-149,592 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 0.00% | 2.08% |
Sold All 😨
(Was: #17) |
0.0 |
—
|
-848,204 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 0.00% | 14.80% |
Sold All 😨
(Was: #1) |
0.0 |
—
|
-604,534 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-27 of 27 holdings